Source comparison
Pulsatile Secretion Pattern Preservation vs Continuous Elevation
The distinction between CJC-1295 no DAC and its DAC-conjugated counterpart (CJC-1295 with DAC) is not trivial marketing. It represents two fundamentally different pharmacological strategies. DAC (Drug Affinity Complex) conjugation extends the peptide's half-li
This comparison does not assign a generated winner or score.
- The distinction between CJC-1295 no DAC and its DAC-conjugated counterpart (CJC-1295 with DAC) is not trivial marketing. It represents two fundamentally different pharmacological strategies. DAC (Drug Affinity Complex) conjugation extends the peptide's half-life from 30 minutes to 6–8 days by binding the molecule to serum albumin, creating a sustained-release depot effect. This produces continuous, low-level GHRH receptor occupancy that elevates baseline GH and IGF-1 levels but flattens the natural pulsatile pattern.
- Physiological GH secretion occurs in discrete pulses. Typically 6–12 pulses per 24-hour period, with the largest pulses occurring during slow-wave sleep. These pulses are not random: they are gated by the opposing actions of GHRH (stimulatory) and somatostatin (inhibitory), both released from the hypothalamus in a coordinated rhythm. Somatostatin acts as a functional 'off switch' between pulses, allowing GHRH receptors to recycle and resensitise. When GHRH receptor occupancy is continuous. As with DAC variants. Somatostatin cannot fully suppress GH release between pulses, and the pituitary compensates by downregulating receptor expression.
- Studies on chronic GHRH infusion in animal models demonstrate receptor internalisation and reduced GH response to subsequent GHRH challenge within 72 hours of continuous exposure. CJC-1295 no DAC avoids this by clearing between pulses. The peptide is administered 1–3 times daily, timed to coincide with natural GH pulse windows (upon waking, pre-workout, or before sleep). Each injection amplifies one pulse, then clears before the next, preserving the receptor's responsiveness across weeks or months of use.
- The metabolic signalling downstream of pulsatile vs sustained GH elevation is not equivalent. Pulsatile GH secretion drives hepatic IGF-1 synthesis more efficiently than continuous low-level GH, and lipolytic signalling in adipose tissue is gated by the amplitude of individual GH pulses. Not cumulative GH AUC (area under the curve). This is why no DAC variants are preferred in research protocols focused on body composition rather than generalised anabolism.